Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.

por Begent, R. H., Chester, K. A., Walker, L. C., Tucker, D. F.
Publicado 1982

Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)

por Mayer, A, Sharma, S K, Tolner, B, Minton, N P, Purdy, D, Amlot, P, Tharakan, G, Begent, R H J, Chester, K A
Publicado 2004

Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification.

por Delgado, C., Pedley, R. B., Herraez, A., Boden, R., Boden, J. A., Keep, P. A., Chester, K. A., Fisher, D., Begent, R. H., Francis, G. E.
Publicado 1996

Clinical Applications of Phage-Derived sFvs and sFv Fusion Proteins

por Chester, K. A., Bhatia, J., Boxer, G., Cooke, S. P., Flynn, A. A., Huhalov, A., Mayer, A., Pedley, R. B., Robson, L., Sharma, S. K., Spencer, D. I. R., Begent, R. H. J.
Publicado 2000